Skip to main content
. Author manuscript; available in PMC: 2016 Mar 16.
Published in final edited form as: Vaccine. 2009 Aug 15;27(44):6234–6238. doi: 10.1016/j.vaccine.2009.07.107

Table 1.

HA antibody levels (EU) and hemagglutination inhibition (HI) response in mice

G.M. IgG anti-HA No. with
Immunogen Dosage EU (25-75 centiles) HI ≥40
rHA-alum 5 μg × 2 14.4 (10.6-21.2) 8/10
rHA-alum 5 μg × 3 177.8 (112-286) 8/10
rHA-formalin 5 μg × 2 26.6 (22.2-41.3) 8/10
rHA-formalin 5 μg × 3 40.1 (33.5-52.2 10/10
rHA-formalin-alum 5 μg × 2 14.4 (10.9-20.1) 3/10
rHA-formalin-alum 5 μg × 3 212.7 (119.3-270.8) 10/10
rHA-alum-formalin 5 μg × 2 3.2 (1.7-9.15) 5/10
rHA-alum-formalin 5 μg × 3 10.0 (7.95-17.1) 9/10
rHA 5 μg × 3 61.5 (24.7-249) 9/9
rHA-alum 15 μg × 3 449.4 (224-757) 10/10
PBS (control) 0.01 (0.005-0.005) 0/10

Mice, 5-6 week old, were injected s.c. 2 or 3 times 2 weeks apart and bled 1 week after the last injection.

14.4 vs 177.8, 212.7 p<0.0001; 26.6 vs 40.1 p Not Significant (NS);

3.2 vs 10 p NS; 177.8 vs 40.1, 10 p<0.0001; 177.8 vs 212.7 p NS;

449.4 vs 177.8, 212.7 p<0.01